Statement Regarding Media Report

Disclosure Date: June 19, 115 Statement Date: June 18, 115 Statement Time: 11:17:37 Company Code: 6446 Company Name: PharmaEssentia Corp.

Subject: Clarification on Media Report Applicable Clause: Clause 51 Factual Date: June 18, 115

Explanation: 1. Factual Date: June 18, 115 2. Company Name: PharmaEssentia Corporation 3. Relationship with Company: Parent Company 4. Cross-shareholding Ratio: Not applicable 5. Media Outlet: China Times Business News 6. Report Content: On June 18, 115, China Times Business News reported: "Analysts project annual revenue could surpass NT$20 billion, setting a new record, with profits exceeding NT$2 per share, potentially making the company the most profitable in the biotech sector." 7. Reason for Disclosure: Response to media report 8. Countermeasures: The company has not released any predictive financial or business information. The financial forecasts regarding the company published by China Times Business News are purely media and analyst estimates. Investors should refer to disclosures on the "Public Information Observation Station" for accurate financial and business updates. 9. Other Matters: New drug development involves long timelines, high investment costs, and no guarantee of success, posing potential investment risks. Investors are advised to make cautious judgments and invest prudently.